SCHEMBL6683540

SCHEMBL6683540

CC(C)(CCC(N)=O)C(C)(C)C(N)=O

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.33
GMNN O75496 1/20 0.33
USP2 O75604 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
GLA P06280 1/20 0.33
POLB P06746 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
CYP2C19 P33261 1/20 0.33
THPO P40225 1/20 0.33
RECQL P46063 1/20 0.33
BLM P54132 1/20 0.33
PMP22 Q01453 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3293803 0.82 LMNA (0.38) KDM4EGMNNUSP2ALDH1A1LMNA
Hydrochloric Acid SCHEMBL6214815 0.80 LMNA (0.36) KDM4EGMNNUSP2ALDH1A1LMNA
SCHEMBL12708040 0.80 KMT2A (0.31) KDM4EGMNNUSP2ALDH1A1LMNA
SCHEMBL31246329 0.78 LMNA (0.43) ALDH1A1LMNACYP3A4HSD17B10TDP1
SCHEMBL232206 0.75 KDM4E (0.36) KDM4EGMNNUSP2ALDH1A1LMNA
SCHEMBL10437649 0.75 KDM4E (0.31) KDM4EGMNNUSP2ALDH1A1LMNA
SCHEMBL28358698 0.74
SCHEMBL8849840 0.74 SOAT1 (0.37) KDM4ETP53CYP1A2CYP3A4CYP2C19
SCHEMBL179561 0.74
Hydrochloric Acid SCHEMBL561987 0.73 KDM4E (0.35) KDM4EGMNNUSP2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210206899-A1 SYNTHESIS OF JANUS DENDRIMERS Sahand University of Technology (IR) 2021-07-08 US claimed
EP-0304134-A2 Magnetic resin composition DSM N.V. (NL) 1989-02-22 EP claimed
US-12590089-B2 Processes for preparing toll-like receptor modulator compounds GILEAD SCIENCES, INC. (US) 2026-03-31 US disclosed
CN-118871522-A High performance polymer composition containing carbon nanostructures 提克纳有限责任公司 2024-10-29 CN disclosed
CN-118435715-A EMI shielding polymer composition 提克纳有限责任公司 2024-08-02 CN disclosed
CN-118401534-A Flame retardant thermoplastic polymer composition 国际人造丝公司 2024-07-26 CN disclosed
CN-118382793-A Technique for testing ball indentation performance of a sample 提克纳有限责任公司 2024-07-23 CN disclosed
CN-117898032-A Multilayer composite for EMI shielding 提克纳有限责任公司 2024-04-16 CN disclosed
CN-116769222-A Polyamide resin foam particles for fiber-reinforced resin composite core material, and fiber-reinforced resin composite 株式会社JSP 2023-09-19 CN disclosed
CN-109476694-B Nucleotide compounds 奇根科学有限责任公司 2022-09-30 CN disclosed
US-20220274985-A1 PROCESSES FOR PREPARING TOLL-LIKE RECEPTOR MODULATOR COMPOUNDS GILEAD SCIENCES, INC. 2022-09-01 US disclosed
CN-103140472-A Process for preparing esteramide compounds RHODIA OPERATIONS 2013-06-05 CN disclosed
CN-101646646-A Novel two (dialkyl amide) compound, preparation method and purposes RHODIA OPERATIONS FR 2010-02-10 CN disclosed
WO-2004058887-A1 POLYOXYMETHYLENE RESIN COMPOSITION KOLON INDUSTRIES, INC. (KR) 2004-07-15 WO disclosed
WO-1998003262-A1 AN IMPROVED PROCESS FOR THE CONVERSION OF FATTY AMIDES TO AMINES STEPAN COMPANY (US) 1998-01-29 WO disclosed
US-5017420-A Surface coating of copper sulfide; high ductility flexibility and heat resistance HOECHST CELANESE CORP. (US) 1991-05-21 US disclosed
US-4868008-A COPPER SULFIDE HOECHST CELANESE CORP. (US) 1989-09-19 US disclosed
US-4826502-A Sulfonation of hydroxyethylated polybenzimidazole fibers HOECHST CELANESE CORP. (US) 1989-05-02 US disclosed
US-4759986-A Associated with covellite copper sulfide HOECHST CELANESE CORPORATION (US) 1988-07-26 US disclosed
US-4634530-A Chemical modification of preformed polybenzimidazole semipermeable membrane CELANESE CORPORATION (US) 1987-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12590089-B2 Processes for preparing toll-like receptor modulator compounds TLR8, MYD88, TLR6 KDM4E 1861/4885GMNN 4435/4885USP2 2258/4885
US-20220274985-A1 PROCESSES FOR PREPARING TOLL-LIKE RECEPTOR MODULATOR COMPOUNDS TLR4, TLR3, TLR6 KDM4E 1287/4885GMNN 4103/4885USP2 2241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.